US 12,410,383 B2
Process of making a treatment composition that includes a plant rosin material and related premix compositions
Mattia Collu, Saint-Gilles (BE); Cédric Marc Tahon, Oost-Vlaanderen (BE); Johan Smets, Lubbeek (BE); Jef Annie Alfons Maes, Sint-Niklaas (BE); Ilse Maria Cyrilla D'Haeseleer, Dendermonde (BE); Katrien Maria Nuyts, Brussels (BE); and Abel Jerez Gomez, Brussels (BE)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Dec. 14, 2021, as Appl. No. 17/549,919.
Claims priority of provisional application 63/125,987, filed on Dec. 16, 2020.
Prior Publication US 2022/0186148 A1, Jun. 16, 2022
Int. Cl. C11D 1/00 (2006.01); C11D 3/00 (2006.01); C11D 3/38 (2006.01); C11D 3/382 (2006.01); C11D 3/50 (2006.01); C11D 11/00 (2006.01)
CPC C11D 3/382 (2013.01) [C11D 3/0015 (2013.01); C11D 3/50 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A process of making a treatment composition, the process comprising the steps of:
providing a base composition,
wherein the base composition comprises an adjunct material; and
adding a plant rosin material and one or more benefit agents to the base composition, wherein the plant rosin material is added with or after the one or more benefit agents and the plant rosin material comprises a plant rosin ester comprising glycerol, pentaerythritol, or both.